MBRX · Moleculin Biotech, Inc. · Documents
$6.50
+0.61 (+10.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.33M
Shares
973,869
Volume · Oct 23
27.74K
Avg daily vol (4 sessions)
65.18K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-10-29 | — | |
| 8-K | — | 2020-10-21 | — | |
| 8-K | — | 2020-10-13 | — | |
| 8-K | — | 2020-10-07 | 2020-10-02 | |
| 8-K | — | 2020-10-06 | — | |
| 8-K | — | 2020-10-02 | 2020-09-30 | |
| 8-K | — | 2020-10-01 | — | |
| 8-K | — | 2020-09-29 | — | |
| 8-K | — | 2020-09-14 | — | |
| 8-K | — | 2020-09-14 | — | |
| 8-K | — | 2020-09-09 | — | |
| 8-K | — | 2020-09-01 | — | |
| 8-K | — | 2020-08-26 | 2020-08-21 | |
| 8-K | — | 2020-08-12 | — | |
| 10-Q | — | 2020-08-12 | 2020-06-30 | |
| 8-K/A | — | 2020-08-04 | 2020-06-11 | |
| 8-K | — | 2020-07-21 | — | |
| 8-K | — | 2020-07-17 | — | |
| 8-K | — | 2020-07-15 | — | |
| 8-K | — | 2020-07-02 | — | |
| 8-K | — | 2020-07-01 | — | |
| 8-K | — | 2020-06-25 | — | |
| 8-K | — | 2020-06-17 | 2020-06-11 | |
| 8-K | — | 2020-06-16 | — | |
| 8-K | — | 2020-05-28 | 2020-05-27 | |
| 8-K | — | 2020-05-27 | 2020-05-20 | |
| 8-K | — | 2020-05-18 | — | |
| DEFA14A | — | 2020-05-15 | — | |
| 10-Q | — | 2020-05-11 | 2020-03-31 | |
| 8-K | — | 2020-05-11 | — | |
| DEFA14A | — | 2020-05-08 | — | |
| 8-K | — | 2020-04-23 | — | |
| 8-K | — | 2020-04-22 | — | |
| 8-K | — | 2020-04-17 | 2020-04-16 | |
| 8-K | — | 2020-04-15 | — | |
| 8-K | — | 2020-04-14 | — | |
| 8-K | — | 2020-04-08 | — | |
| DEF 14A | — | 2020-04-07 | — | |
| 8-K | — | 2020-04-02 | — | |
| PRE 14A | — | 2020-03-27 | — | |
| 8-K | — | 2020-03-26 | 2020-03-20 | |
| S-3/A | — | 2020-03-23 | — | |
| 10-K | — | 2020-03-19 | 2019-12-31 | |
| 8-K | — | 2020-03-19 | — | |
| 8-K | — | 2020-03-17 | 2020-03-16 | |
| 8-K | — | 2020-03-16 | 2020-03-13 | |
| 8-K | — | 2020-03-10 | — | |
| 8-K | — | 2020-03-04 | — | |
| 8-K | — | 2020-02-20 | — |
Showing 351–400 of 407 filings